Kiniksa Pharmaceuticals L...
18.81
0.47 (2.56%)
At close: Jan 15, 2025, 10:45 AM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio 87.25 5.67 -5.11 -6.77 -3.69 -8.04 -9.74 -26.37
PS Ratio 4.55 4.72 20.94 n/a n/a n/a n/a n/a
PB Ratio 2.80 -2.11 -1.2 -2.11 -1.68 -4.27 -7.05 -24.57
P/FCF Ratio 93.30 182.28 -5.5 -7.99 -3.7 -9.62 -12.57 -28.9
P/OCF Ratio 92.39 178.98 -6.39 -8 -3.77 -10.25 -12.59 -28.91
OCF/S Ratio 0.05 0.03 -3.28 n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.03 -0.01 -0.01 -0.01 -0.01 n/a n/a n/a
Quick Ratio 3.85 4.71 4.30 10.46 8.68 7.37 2.70 24.47
Current Ratio 4.34 5.16 4.38 10.46 8.68 7.37 2.70 24.47
Asset Turnover 0.51 0.48 0.17 n/a n/a n/a n/a n/a
Interest Coverage n/a 5.88 n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) 0.03 -0.37 0.23 0.31 0.45 0.53 0.72 0.93
Return on Assets (ROA) 0.03 0.40 -0.68 -0.46 -0.64 -0.32 -1.37 -0.42
Return on Capital (ROIC) -0.05 0.02 -0.83 -0.5 -0.75 -0.39 -2.18 -0.44
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 79.09% 78.67% 76.39% n/a n/a n/a n/a n/a
Net Profit Margin 5.21% 83.28% -409.72% n/a n/a n/a n/a n/a
Pretax Profit Margin -6.16% 5.01% -406.13% n/a n/a n/a n/a n/a
Operating Profit Margin -9.32% 3.35% -406.38% n/a n/a n/a n/a n/a
FCF Margin 4.87% 2.59% -380.64% n/a n/a n/a n/a n/a
EBITDA Margin -8.46% 4.44% -400.27% n/a n/a n/a n/a n/a